Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer immunotherapy

LINKing signaling domains to enhance CAR T cells

Nature Cancer volume 4, pages 447–449 (2023) Cite this article

Subjects

The lack of tumor-specific surface antigens has limited the application of CAR T cells in solid tumors. A new AND-gated CAR T cell system repurposes proximal T cell signaling proteins to restrict activation to dual antigen encounter, mitigating on-target, off-tumor toxicity while preserving antitumor efficacy in preclinical models.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Leveraging the cooperative role of LAT and SLP-76 in LINK CARs to prevent on-target, off-tumor toxicity.
The alternative text for this image may have been generated using AI.

References

  1. Tousley, A. M. et al. Nature 615, 507–516 (2023).

    Article  CAS  PubMed  Google Scholar 

  2. June, C. H. & Sadelain, M. N. Engl. J. Med. 379, 64–73 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Nat. Biotechnol. 31, 71–75 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. Roybal, K. T. et al. Cell 167, 419–432 e416 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cho, J. H., Collins, J. J. & Wong, W. W. Cell 173, 1426–1438 e1411 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lajoie, M. J. et al. Science 369, 1637–1643 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Srivastava, S. et al. Cancer Cell 35, 489–503 e488 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Majzner, R. G. et al. Cancer Discov. 10, 702–723 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hamieh, M. et al. Nature 568, 112–116 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhao, Z. et al. Cancer Cell 28, 415–428 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Daniels, K. G. et al. Science 378, 1194–1200 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kawalekar, O. U. et al. Immunity 44, 380–390 (2016).

    Article  CAS  PubMed  Google Scholar 

  13. Mackensen, A. et al. Nat. Med. 28, 2124–2132 (2022).

    Article  CAS  PubMed  Google Scholar 

  14. Rurik, J. G. et al. Science 375, 91–96 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Amor, C. et al. Nature 583, 127–132 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cluster of Excellence iFIT (EXC2180) “Image-guided and Functionally Instructed Tumor Therapies,” University of Tübingen, Tübingen, Germany

    Philip Bucher & Judith Feucht

  2. Department of Pediatric Hematology and Oncology, University Children’s Hospital, University of Tübingen, Tübingen, Germany

    Philip Bucher & Judith Feucht

Authors
  1. Philip Bucher
    View author publications

    Search author on:PubMed Google Scholar

  2. Judith Feucht
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Judith Feucht.

Ethics declarations

Competing interests

P.B. declares no financial interests. J.F. is listed as co-inventor of several patents on CAR technologies unrelated to the subject matter of this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bucher, P., Feucht, J. LINKing signaling domains to enhance CAR T cells. Nat Cancer 4, 447–449 (2023). https://doi.org/10.1038/s43018-023-00538-7

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43018-023-00538-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer